BibTex format
@inproceedings{Phillips:2016:10.1182/blood.V128.22.4159.4159,
author = {Phillips, A and Fields, P and Hermine, O and Ramos, JC and Beltran, BE and Pereira, J and Brites, C and Wandroo, FA and Lill, M and Feldman, TA and Casanova, L and Janakiram, M and Meniane, J-C and Sawas, A and Cook, LB and Kurman, MR and George, J and Dwyer, K and Leoni, M and Conlon, K and Taylor, GP and Gonsky, J and Horwitz, SM},
doi = {10.1182/blood.V128.22.4159.4159},
pages = {4159--4159},
publisher = {American Society of Hematology},
title = {A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab versus investigator's choice in the treatment of patients with relapsed/Refractory adult tTcell leukemia-lymphoma: overall response rate, progression-free survival, and overall survival},
url = {http://dx.doi.org/10.1182/blood.V128.22.4159.4159},
year = {2016}
}
RIS format (EndNote, RefMan)
TY - CPAPER
AU - Phillips,A
AU - Fields,P
AU - Hermine,O
AU - Ramos,JC
AU - Beltran,BE
AU - Pereira,J
AU - Brites,C
AU - Wandroo,FA
AU - Lill,M
AU - Feldman,TA
AU - Casanova,L
AU - Janakiram,M
AU - Meniane,J-C
AU - Sawas,A
AU - Cook,LB
AU - Kurman,MR
AU - George,J
AU - Dwyer,K
AU - Leoni,M
AU - Conlon,K
AU - Taylor,GP
AU - Gonsky,J
AU - Horwitz,SM
DO - 10.1182/blood.V128.22.4159.4159
EP - 4159
PB - American Society of Hematology
PY - 2016///
SN - 0006-4971
SP - 4159
TI - A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab versus investigator's choice in the treatment of patients with relapsed/Refractory adult tTcell leukemia-lymphoma: overall response rate, progression-free survival, and overall survival
UR - http://dx.doi.org/10.1182/blood.V128.22.4159.4159
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394452308057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - https://www.sciencedirect.com/science/article/pii/S0006497119341606
ER -